UCB S.A.-Strategy, SWOT and Corporate Finance Report
- 710C53CF-12C9-486E-B4FA-3CD3361B755C
- Pages: 57
- January 2017
- Total Views:1154
- Region : Europe
- MarketLine
- Equity Research Report

Details
UCB S.A.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Findings
Detailed information on UCB S.A. required for business and competitor intelligence needs
A study of the major internal and external factors affecting UCB S.A. in the form of a SWOT analysis
An in-depth view of the business model of UCB S.A. including a breakdown and examination of key business segments
Intelligence on UCB S.A.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about UCB S.A., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
Gain understanding of UCB S.A. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess UCB S.A. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on UCB S.A.'s business structure, strategy and prospects.
Key Highlights
UCB (or 'the company') is a global biopharmaceutical company focused on the discovery and development for people living with severe diseases of the immune system or of the central nervous system (CNS). It has operations in about 40 countries across Europe, North America and Asia Pacific. It is headquartered in Brussels, Belgium, and employed 8,684 people as of December 31, 2014.
Table Of Content
Scope
Company Snapshot
UCB S.A.: Company Overview
UCB S.A.: Overview and Key Facts
UCB S.A.: Overview
UCB S.A.: Key Facts
UCB S.A.: Key Employees
UCB S.A.: Key Employee Biographies
UCB S.A.: Major Products and Services
UCB S.A.: Company History
UCB S.A.: Management Statement
UCB S.A.: Locations and Subsidiaries
UCB S.A.: Key Competitors
UCB S.A.: Company Analysis
UCB S.A.: Business Description
UCB S.A.: SWOT Analysis
UCB S.A.: SWOT Overview
UCB S.A.: Strengths
UCB S.A.: Weaknesses
UCB S.A.: Opportunities
UCB S.A.: Threats
UCB S.A.: Corporate Financial Deals Activity
UCB S.A.: Financial Deals Overview
UCB S.A.: Targets and Partners
UCB S.A.: Top Deals 2013-2017YTD*
UCB S.A.: Mergers and Acquisitions
UCB S.A.: Corporate Venturing
UCB S.A.: Partnership
UCB S.A.: Divestments
UCB S.A.: Recent Developments
UCB S.A.: News and Events Summary
UCB S.A.: Business Expansion
UCB S.A.: Corporate Governance
UCB S.A.: Market Developments
UCB S.A.: Regulatory and Legal Events
UCB S.A.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List Of Figure
Figure 1: UCB S.A.: Deal Activity by Deal Type-Volume (TTM*)
Figure 2: UCB S.A.: Deal Activity by Deal Type-Volume (2013-YTD*2017)
Figure 3: UCB S.A.: M&A Volume and Value Trend (2013-YTD*2017)
Figure 4: UCB S.A.: M&A Activity by Geography (2013-YTD*2017)
Figure 5: UCB S.A.: Corporate Venturing Volume and Value Trend (2013-YTD*2017)
Figure 6: UCB S.A.: Corporate Venturing by Geography (2013-YTD*2017)
Figure 7: UCB S.A.: Partnership Volume and Value Trend (2013-YTD*2017)
Figure 8: UCB S.A.: Partnership Trend by Deal Type (2013-YTD*2017)
Figure 9: UCB S.A.: Divestments Volume and Value Trend (2013-YTD*2017)
Figure 10: UCB S.A.: Divestments by Geography (2013-YTD*2017)
List Of Table
Table 1: UCB S.A.: Key Facts
Table 2: UCB S.A.: Key Employees
Table 4: UCB S.A.: Key Competitors
Table 5: UCB S.A.: Deal Activity by Deal Type-Volume (TTM*)
Table 6: UCB S.A.: Deal Activity by Deal Type-Volume (2013-YTD*2017)
Table 7: UCB S.A.: Targets and Partners
Table 8: UCB S.A.: Top Deals 2013-2017YTD*
Table 9: UCB S.A.: M&A Volume and Value Trend (2013-YTD*2017)
Table 10: UCB S.A.: M&A Activity by Geography (2013-YTD*2017)
Table 11: UCB S.A.: Corporate Venturing Volume and Value Trend (2013-YTD*2017)
Table 12: UCB S.A.: Corporate Venturing by Geography (2013-YTD*2017)
Table 13: UCB S.A.: Partnership Volume and Value Trend (2013-YTD*2017)
Table 14: UCB S.A.: Partnership Trend by Deal Type (2013-YTD*2017)
Table 15: UCB S.A.: Divestments Volume and Value Trend (2013-YTD*2017)
Table 16: UCB S.A.: Divestments by Geography (2013-YTD*2017)
Table 17: UCB S.A.: News and Events Summary
Table 18: UCB S.A.: Business Expansion
Table 19: UCB S.A.: Corporate Governance
Table 20: UCB S.A.: Market Developments
Table 21: UCB S.A.: Regulatory and Legal Events
Table 22: UCB S.A.: Research & Development
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Companies
UCB S.A.
Company Profile
Company Profile Title
UCB S.A.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Findings
Detailed information on UCB S.A. required for business and competitor intelligence needs
A study of the major internal and external factors affecting UCB S.A. in the form of a SWOT analysis
An in-depth view of the business model of UCB S.A. including a breakdown and examination of key business segments
Intelligence on UCB S.A.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about UCB S.A., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
Gain understanding of UCB S.A. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess UCB S.A. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on UCB S.A.'s business structure, strategy and prospects.
Key Highlights
UCB (or 'the company') is a global biopharmaceutical company focused on the discovery and development for people living with severe diseases of the immune system or of the central nervous system (CNS). It has operations in about 40 countries across Europe, North America and Asia Pacific. It is headquartered in Brussels, Belgium, and employed 8,684 people as of December 31, 2014.
Scope
Company Snapshot
UCB S.A.: Company Overview
UCB S.A.: Overview and Key Facts
UCB S.A.: Overview
UCB S.A.: Key Facts
UCB S.A.: Key Employees
UCB S.A.: Key Employee Biographies
UCB S.A.: Major Products and Services
UCB S.A.: Company History
UCB S.A.: Management Statement
UCB S.A.: Locations and Subsidiaries
UCB S.A.: Key Competitors
UCB S.A.: Company Analysis
UCB S.A.: Business Description
UCB S.A.: SWOT Analysis
UCB S.A.: SWOT Overview
UCB S.A.: Strengths
UCB S.A.: Weaknesses
UCB S.A.: Opportunities
UCB S.A.: Threats
UCB S.A.: Corporate Financial Deals Activity
UCB S.A.: Financial Deals Overview
UCB S.A.: Targets and Partners
UCB S.A.: Top Deals 2013-2017YTD*
UCB S.A.: Mergers and Acquisitions
UCB S.A.: Corporate Venturing
UCB S.A.: Partnership
UCB S.A.: Divestments
UCB S.A.: Recent Developments
UCB S.A.: News and Events Summary
UCB S.A.: Business Expansion
UCB S.A.: Corporate Governance
UCB S.A.: Market Developments
UCB S.A.: Regulatory and Legal Events
UCB S.A.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List Of Figure
Figure 1: UCB S.A.: Deal Activity by Deal Type-Volume (TTM*)
Figure 2: UCB S.A.: Deal Activity by Deal Type-Volume (2013-YTD*2017)
Figure 3: UCB S.A.: M&A Volume and Value Trend (2013-YTD*2017)
Figure 4: UCB S.A.: M&A Activity by Geography (2013-YTD*2017)
Figure 5: UCB S.A.: Corporate Venturing Volume and Value Trend (2013-YTD*2017)
Figure 6: UCB S.A.: Corporate Venturing by Geography (2013-YTD*2017)
Figure 7: UCB S.A.: Partnership Volume and Value Trend (2013-YTD*2017)
Figure 8: UCB S.A.: Partnership Trend by Deal Type (2013-YTD*2017)
Figure 9: UCB S.A.: Divestments Volume and Value Trend (2013-YTD*2017)
Figure 10: UCB S.A.: Divestments by Geography (2013-YTD*2017)
List Of Table
Table 1: UCB S.A.: Key Facts
Table 2: UCB S.A.: Key Employees
Table 4: UCB S.A.: Key Competitors
Table 5: UCB S.A.: Deal Activity by Deal Type-Volume (TTM*)
Table 6: UCB S.A.: Deal Activity by Deal Type-Volume (2013-YTD*2017)
Table 7: UCB S.A.: Targets and Partners
Table 8: UCB S.A.: Top Deals 2013-2017YTD*
Table 9: UCB S.A.: M&A Volume and Value Trend (2013-YTD*2017)
Table 10: UCB S.A.: M&A Activity by Geography (2013-YTD*2017)
Table 11: UCB S.A.: Corporate Venturing Volume and Value Trend (2013-YTD*2017)
Table 12: UCB S.A.: Corporate Venturing by Geography (2013-YTD*2017)
Table 13: UCB S.A.: Partnership Volume and Value Trend (2013-YTD*2017)
Table 14: UCB S.A.: Partnership Trend by Deal Type (2013-YTD*2017)
Table 15: UCB S.A.: Divestments Volume and Value Trend (2013-YTD*2017)
Table 16: UCB S.A.: Divestments by Geography (2013-YTD*2017)
Table 17: UCB S.A.: News and Events Summary
Table 18: UCB S.A.: Business Expansion
Table 19: UCB S.A.: Corporate Governance
Table 20: UCB S.A.: Market Developments
Table 21: UCB S.A.: Regulatory and Legal Events
Table 22: UCB S.A.: Research & Development
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Companies
UCB S.A.